Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif., January 21, 2025--(BUSINESS WIRE)--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading ...

Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...

Interim CEO Michelle Brennan Named Chairman of Masimo’s Board Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie ...

Masimo (MASI) announced that Katie Szyman has been appointed the next Chief Executive Officer of the Company. Interim CEO Michelle Brennan has been appointed Chairman of Masimo’s Board and Lead ...

Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2024 on Thursday. Following the robust preliminary results, the company’s shares gained nearly 0.1% ...

Masimo MASI1.29%increase; green up pointing triangle appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company’s founder. Szyman will become CEO of ...

Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company's founder. Szyman will become CEO of the medical-device maker Feb. 12, replacing ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief Executive ...

Masimo Corp. today announced Katie Szyman as its new chief executive, effective Feb. 12. Szyman is currently worldwide president of BD Advanced Patient Monitoring, the former Critical Care unit of ...

In examining recent analyst actions, we gain insights into how financial experts perceive Masimo. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings ...